The researchers concluded that zinc supplementation and a high zinc/iron intake ratio may lower the risk of T2DM, but these relations could be modified by obesity and the SLC30A8 genotype. This evidence concerns the gene SLC30A8 and obesity due to melanocortin 4 receptor deficiency.